NCT04164693View on ClinicalTrials.gov

Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula

NACompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

September 1, 2022

Study Completion Date

September 30, 2022

Conditions
Thrombosis
Interventions
DRUG

Low molecular weight heparin

patients began to use low molecular weight heparin or warfarin sodium tablets.

OTHER

non anticoagulant therapy group

no anticoagulant was used after operation.

Trial Locations (1)

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

First Affiliated Hospital of Chongqing Medical University

OTHER

NCT04164693 - Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula | Biotech Hunter | Biotech Hunter